Search

Your search keyword '"Balschun, T"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Balschun, T" Remove constraint Author: "Balschun, T"
45 results on '"Balschun, T"'

Search Results

1. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants

2. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

3. High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

4. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

5. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

6. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry

7. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1,2q22.3 and 17q21.32

9. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)

10. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

11. Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis

12. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

13. Combined analysis of Genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci

14. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32

15. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

16. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.

17. 1400 DISCOVERY OF A DIRECT ASSOCIATION BETWEEN PRIMARY BILIARY CIRRHOSIS AND LOW BONE MASS: IDENTIFICATION OF TNFSF11/RANKL AS A RISK LOCUS FOR PATIENTS WITH PBC

19. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

20. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry

21. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

22. The age related markers lipofuscin and apoptosis show different genetic architecture by QTL mapping in short-lived Nothobranchius fish

23. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

24. The age related markers lipofuscin and apoptosis show different genetic architecture by QTL mapping in short-lived Nothobranchius fish.

25. Replication study of ulcerative colitis risk loci in a Lithuanian-Latvian case-control sample.

26. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.

27. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus.

28. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32.

29. Genetic variants in Protocadherin-1, bronchial hyper-responsiveness, and asthma subphenotypes in German children.

30. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

31. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci.

32. A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology.

33. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites.

34. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.

35. Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.

36. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.

37. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

38. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

39. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).

40. Genome-wide association analysis in primary sclerosing cholangitis.

41. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.

42. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

43. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2.

44. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

45. Systematic association mapping identifies NELL1 as a novel IBD disease gene.

Catalog

Books, media, physical & digital resources